These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12518385)

  • 1. [Research on superantigenic toxins integrating bacteriology, immunology, bacterial toxins, and clinical infections diseases].
    Uchiyama T
    Nihon Saikingaku Zasshi; 2002 Nov; 57(4):563-79. PubMed ID: 12518385
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular and molecular mechanisms of immune activation by microbial superantigens: studies using toxic shock syndrome toxin-1.
    Chatila T; Scholl P; Ramesh N; Trede N; Fuleihan R; Morio T; Geha RS
    Chem Immunol; 1992; 55():146-71. PubMed ID: 1418616
    [No Abstract]   [Full Text] [Related]  

  • 3. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G; Levy R; Hillman D; Kaempfer R
    Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel superantigenic exotoxin from Yersinia psuedotuberculosis and its position in the classification of the entire bacterial toxins.
    Uchiyama T
    Contrib Microbiol Immunol; 1995; 13():191-4. PubMed ID: 8833831
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stimulation of the immune system by microbial "superantigens"].
    Fleischer B
    Immun Infekt; 1991 Feb; 19(1):8-11. PubMed ID: 2060968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
    Bohach GA; Fast DJ; Nelson RD; Schlievert PM
    Crit Rev Microbiol; 1990; 17(4):251-72. PubMed ID: 2206394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Superantigens and antigen recognition of T lymphocytes].
    Gülmezoğlu E
    Mikrobiyol Bul; 1993 Apr; 27(2):164-70. PubMed ID: 8502189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein.
    Ito Y; Abe J; Yoshino K; Takeda T; Kohsaka T
    J Immunol; 1995 Jun; 154(11):5896-906. PubMed ID: 7751634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defense against biologic warfare with superantigen toxins.
    Kaempfer R; Arad G; Levy R; Hillman D
    Isr Med Assoc J; 2002 Jul; 4(7):520-3. PubMed ID: 12120463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacterial enterotoxins bearing superantigenic properties].
    Miyoshi-Akiyama T; Uchiyama T
    Nihon Saikingaku Zasshi; 1995; 50(2):501-8. PubMed ID: 7623416
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular genetics of pyrogenic exotoxin "superantigens" of group A streptococci and Staphylococcus aureus.
    Lee PK; Schlievert PM
    Curr Top Microbiol Immunol; 1991; 174():1-19. PubMed ID: 1802616
    [No Abstract]   [Full Text] [Related]  

  • 12. [Emerging infectious diseases--MRSA infections].
    Yokoyama T; Takesue Y; Hiyama E; Murakami Y
    Nihon Naika Gakkai Zasshi; 1997 Nov; 86(11):2064-8. PubMed ID: 9480311
    [No Abstract]   [Full Text] [Related]  

  • 13. Expanding perspectives on the toxic shock syndrome.
    Freedman JD; Beer DJ
    Adv Intern Med; 1991; 36():363-97. PubMed ID: 2024587
    [No Abstract]   [Full Text] [Related]  

  • 14. Purification and gene cloning of a superantigen (YPM) produced by a patient strain of Yersinia pseudotuberculosis.
    Takeda T; Yoshino K; Itoh Y; Abe J; Shimonishi Y; Kohsaka T
    Contrib Microbiol Immunol; 1995; 13():331-3. PubMed ID: 8833866
    [No Abstract]   [Full Text] [Related]  

  • 15. Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology.
    Betley MJ; Borst DW; Regassa LB
    Chem Immunol; 1992; 55():1-35. PubMed ID: 1418613
    [No Abstract]   [Full Text] [Related]  

  • 16. Methicillin-resistant Staphylococcus aureus toxic shock syndrome.
    Walden A; Harriet H; Alyaqoobi M
    J Infect; 2008 Feb; 56(2):161-2. PubMed ID: 18082891
    [No Abstract]   [Full Text] [Related]  

  • 17. Superantigens and streptococcal toxic shock syndrome.
    Proft T; Sriskandan S; Yang L; Fraser JD
    Emerg Infect Dis; 2003 Oct; 9(10):1211-8. PubMed ID: 14609454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superantigen can reactivate bacterial cell wall-induced arthritis.
    Schwab JH; Brown RR; Anderle SK; Schlievert PM
    J Immunol; 1993 May; 150(9):4151-9. PubMed ID: 8473753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
    Norton SD; Schlievert PM; Novick RP; Jenkins MK
    J Immunol; 1990 Mar; 144(6):2089-95. PubMed ID: 2313089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens.
    Sriskandan S; Faulkner L; Hopkins P
    Int J Biochem Cell Biol; 2007; 39(1):12-9. PubMed ID: 17029999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.